Invesco Nasdaq Biotechnology Etf Probability Of Bankruptcy

IBBQ Etf  USD 23.20  0.19  0.83%   
Invesco Nasdaq's risk of distress is under 9% at this time. It has tiny likelihood of undergoing some form of financial distress in the near future. Probability of distress prediction helps decision makers evaluate Invesco Nasdaq's chance of financial distress in relation to its going-concern outlook and evaluation. Check out Invesco Nasdaq Piotroski F Score and Invesco Nasdaq Altman Z Score analysis.
  

Invesco Nasdaq Biotechnology ETF probability of distress Analysis

Invesco Nasdaq's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Invesco Nasdaq Probability Of Bankruptcy

    
  Less than 9%  
Most of Invesco Nasdaq's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Invesco Nasdaq Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Invesco Nasdaq probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Invesco Nasdaq odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Invesco Nasdaq Biotechnology financial health.
The market value of Invesco Nasdaq Biote is measured differently than its book value, which is the value of Invesco that is recorded on the company's balance sheet. Investors also form their own opinion of Invesco Nasdaq's value that differs from its market value or its book value, called intrinsic value, which is Invesco Nasdaq's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invesco Nasdaq's market value can be influenced by many factors that don't directly affect Invesco Nasdaq's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invesco Nasdaq's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invesco Nasdaq is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invesco Nasdaq's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Invesco Nasdaq Biotechnology has a Probability Of Bankruptcy of 9.0%. This is much higher than that of the Invesco family and significantly higher than that of the Health category. The probability of bankruptcy for all United States etfs is notably lower than that of the firm.

Invesco Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Invesco Nasdaq's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Invesco Nasdaq could also be used in its relative valuation, which is a method of valuing Invesco Nasdaq by comparing valuation metrics of similar companies.
Invesco Nasdaq is currently under evaluation in probability of bankruptcy as compared to similar ETFs.

Invesco Fundamentals

About Invesco Nasdaq Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Invesco Nasdaq Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Invesco Nasdaq using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Invesco Nasdaq Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Invesco Nasdaq

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Invesco Nasdaq position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco Nasdaq will appreciate offsetting losses from the drop in the long position's value.

Moving together with Invesco Etf

  0.8XLV Health Care SelectPairCorr
  0.85VHT Vanguard Health CarePairCorr
  0.98IBB iShares Biotechnology ETFPairCorr
  0.9XBI SPDR SP BiotechPairCorr

Moving against Invesco Etf

  0.48VO Vanguard Mid CapPairCorr
  0.42VUG Vanguard Growth IndexPairCorr
  0.41VB Vanguard Small CapPairCorr
  0.4VTI Vanguard Total StockPairCorr
  0.39SPY SPDR SP 500 Aggressive PushPairCorr
The ability to find closely correlated positions to Invesco Nasdaq could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Invesco Nasdaq when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Invesco Nasdaq - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Invesco Nasdaq Biotechnology to buy it.
The correlation of Invesco Nasdaq is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Invesco Nasdaq moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Invesco Nasdaq Biote moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Invesco Nasdaq can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Invesco Nasdaq Biote is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Invesco Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Invesco Nasdaq Biotechnology Etf. Highlighted below are key reports to facilitate an investment decision about Invesco Nasdaq Biotechnology Etf:
Check out Invesco Nasdaq Piotroski F Score and Invesco Nasdaq Altman Z Score analysis.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
The market value of Invesco Nasdaq Biote is measured differently than its book value, which is the value of Invesco that is recorded on the company's balance sheet. Investors also form their own opinion of Invesco Nasdaq's value that differs from its market value or its book value, called intrinsic value, which is Invesco Nasdaq's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invesco Nasdaq's market value can be influenced by many factors that don't directly affect Invesco Nasdaq's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invesco Nasdaq's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invesco Nasdaq is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invesco Nasdaq's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.